Regulation And Legal
Sun Pharma Denies $12 Billion Organon Deal Speculation
• Sun Pharma responded to BSE/NSE queries denying a speculative news article about a $12 billion Organon deal.
• The company clarified no material event requiring disclosure under SEBI Regulation 30 h
